Clazakizumab

(Synonyms: ALD-518; BMS-945429)
Kundenbewertung

Based on 1 Customer Validation

Clazakizumab (ALD-518; BMS-945429) is a monoclonal antibody inhibitor targeting IL-6 that binds to and blocks IL-6-mediated signaling (including trans-signaling), reducing STAT3 phosphorylation, innate immune cell infiltration, endothelial activation, and complement activation, thereby protecting the kidney from ischemia-reperfusion injury. Clazakizumab can be used in research on renal ischemia-reperfusion injury and obesity-related hypercoagulability.

Nur für Forschungszwecke. Wir verkaufen nicht an Patienten.

  • Reinheit : ≥99.0%
  • CAS. Nr.: 1236278-28-6
  • Molecular Weight:145.234 kDa
  • Speicherung:

    Please store the product under the recommended conditions in the Certificate of Analysis.

  • Biologische Aktivität
  • Chemical Information
  • Protokoll
  • Reinheit & Dokumentation
  • Verweise
  • Help & FAQs

Alle Interleukin Related Isoform-spezifische Produkte anzeigen

More

Alle STAT Isoform-spezifische Produkte anzeigen

More
MOQ
Minimum order quantity
100 mg

Angebot einholen Auf Lager

Other size
Angebot einholen
Please select quantity
Amount: USD 0.00